|
1) Selvin E, Marinopoulos S, berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004; 141: 421-31
|
|
|
|
2) U K Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonyl-ureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 837-53
|
|
|
|
|
3) Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lower-ing in type 2 diabetes. N Engl J Med. 2008; 358: 2545-59
|
|
|
|
|
|
4) ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in pa-tients with type 2 diabetes. N Engl J Med. 2008; 358: 2560-72
|
|
|
|
|
|
5) Duckworth W, Abraira C, Moritz T, et al. Intensive glucose control and complications in American veterans with type 2 diabetes. N Engl J Med. 2009; 360: 129-39
|
|
|
|
|
|
6) Questions and Answers About the ACCORD Clinical Trial. http://www.nhlbi.nih.gov/health/prof/heart/other/accord/q_a.htm
|
|
|
|
|
|
7) Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359: 1577-89
|
|
|
|
|
|
8) Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation. 2009; 119; 351-7
|
|
|
|
|
|
9) Ray KK, Seshasai SRK, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised con-trolled trials. Lancet. 2009; 373: 1765-72
|
|
|
|
|
|
10) Dormandy JA, Charbonnel B, Eckland DJ, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 2005; 366: 1279-89
|
|
|
|
|